OTAQ Plc | Finanzwire

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
OTAQ Plc

PRESS RELEASE

published on 02/01/2024 at 08:00, 9 months 20 days ago

Total Voting Rights
OTAQ plc announces total voting rights as 128,181,025 ordinary shares with voting rights. Shareholders can use this figure to determine their notification obligations under FCA rules

OTAQ Plc Aquaculture Technology Total Voting Rights FCA Disclosure Guidance Offshore Markets
PRESS RELEASE

published on 01/19/2024 at 17:31, 10 months 2 days ago

SIP Purchase, PDMR and Total Voting Rights
OTAQ plc has announced the purchase of 36,665 ordinary shares through its Share Incentive Plan (SIP) for the benefit of participants, including Persons Discharging Managerial Responsibilities in the Company. The issue and allotment of these shares for the SIP Award have been outlined, and details of the number of shares purchased and allocated to PDMRs have been provided. The company also disclosed the total voting rights following this transaction. OTAQ plc is a technology company focused on aquaculture, geotracking, and offshore markets, and the announcement reflects its commitment to incentivizing employees and enhancing its presence in these sectors.

OTAQ Plc SIP Purchase PDMR Share Incentive Plan Aquaculture Technology
PRESS RELEASE

published on 11/01/2023 at 08:00, 1 year ago

Total Voting Rights
PRESS RELEASE

published on 10/18/2023 at 12:52, 1 year 1 month ago

SIP Purchase, PDMR and Total Voting Rights
PRESS RELEASE

published on 10/02/2023 at 08:00, 1 year 1 month ago

Total Voting Rights
PRESS RELEASE

published on 09/27/2023 at 08:00, 1 year 1 month ago

Directorate Change
PRESS RELEASE

published on 09/19/2023 at 16:16, 1 year 2 months ago

SIP Purchase, PDMR and Total Voting Rights
PRESS RELEASE

published on 09/01/2023 at 08:00, 1 year 2 months ago

Total Voting Rights
PRESS RELEASE

published on 08/18/2023 at 17:19, 1 year 3 months ago

SIP Purchase, PDMR and Total Voting Rights
PRESS RELEASE

published on 08/01/2023 at 08:01, 1 year 3 months ago

Total Voting Rights

Accesswire

Published on 11/22/2024 at 00:00, 2 hours 18 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 4 hours 13 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 4 hours 28 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 6 hours 3 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 6 hours 8 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 7 hours 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 7 hours 42 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 8 hours 19 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 8 hours 26 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 8 hours 27 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 19 hours 20 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 6 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 8 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 8 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 18 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE